The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

Many people who take GLP-1 drugs find that their cravings disappear. I went to a Buddhist monastery to understand why that ...

Dopamine also explains why the use of drugs such as cocaine produces pleasure by blocking the absorption of the neurotransmitter and keeping its levels elevated in the body. Although dopaminergic ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...

Results from TEMPO-1, which showed that tavapadon significantly improved motor symptoms in patients with Parkinson’s disease, ...

A new study shows that unexpected sounds can cause dopamine bursts in the brain, which may lead to riskier decision-making.